124 related articles for article (PubMed ID: 33091607)
1. Assessing different thiazolidine and thiazole based compounds as antileishmanial scaffolds.
Schadich E; Kryshchyshyn-Dylevych A; Holota S; Polishchuk P; Džubak P; Gurska S; Hajduch M; Lesyk R
Bioorg Med Chem Lett; 2020 Dec; 30(23):127616. PubMed ID: 33091607
[TBL] [Abstract][Full Text] [Related]
2. Thiazolidinone/thiazole based hybrids - New class of antitrypanosomal agents.
Kryshchyshyn A; Kaminskyy D; Karpenko O; Gzella A; Grellier P; Lesyk R
Eur J Med Chem; 2019 Jul; 174():292-308. PubMed ID: 31051403
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of pyrazoline-thiazolidinone hybrids with trypanocidal activity.
Havrylyuk D; Zimenkovsky B; Karpenko O; Grellier P; Lesyk R
Eur J Med Chem; 2014 Oct; 85():245-54. PubMed ID: 25089808
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 5-enamine-4-thiazolidinone derivatives with trypanocidal and anticancer activity.
Holota S; Kryshchyshyn A; Derkach H; Trufin Y; Demchuk I; Gzella A; Grellier P; Lesyk R
Bioorg Chem; 2019 May; 86():126-136. PubMed ID: 30690336
[TBL] [Abstract][Full Text] [Related]
5. 8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases.
Fersing C; Boudot C; Pedron J; Hutter S; Primas N; Castera-Ducros C; Bourgeade-Delmas S; Sournia-Saquet A; Moreau A; Cohen A; Stigliani JL; Pratviel G; Crozet MD; Wyllie S; Fairlamb A; Valentin A; Rathelot P; Azas N; Courtioux B; Verhaeghe P; Vanelle P
Eur J Med Chem; 2018 Sep; 157():115-126. PubMed ID: 30092366
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of oxysterols and nitrogenous sterols with antileishmanial and trypanocidal activities.
Bazin MA; Loiseau PM; Bories C; Letourneux Y; Rault S; El Kihel L
Eur J Med Chem; 2006 Oct; 41(10):1109-16. PubMed ID: 16949702
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-trypanosomal activity of 3'-fluororibonucleosides derived from 7-deazapurine nucleosides.
Nguyen VH; Tichý M; Rožánková S; Pohl R; Downey AM; Doleželová E; Tloušťová E; Slapničková M; Zíková A; Hocek M
Bioorg Med Chem Lett; 2021 May; 40():127957. PubMed ID: 33741462
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines.
Gamage SA; Figgitt DP; Wojcik SJ; Ralph RK; Ransijn A; Mauel J; Yardley V; Snowdon D; Croft SL; Denny WA
J Med Chem; 1997 Aug; 40(16):2634-42. PubMed ID: 9258370
[TBL] [Abstract][Full Text] [Related]
9. In silico study and in vitro antileishmanial and antitrypanosomal evaluation of azopyrazoles and azopyrimidines.
Am Alkhaldi A; F Lamie P; A Abdelgawad M
Pak J Pharm Sci; 2024 Jan; 37(1(Special)):173-184. PubMed ID: 38747267
[TBL] [Abstract][Full Text] [Related]
10. In vitro trypanocidal activity of dibutyltin dichloride and its fatty acid derivatives.
Shuaibu MN; Kanbara H; Yanagi T; Ichinose A; Ameh DA; Bonire JJ; Nok AJ
Parasitol Res; 2003 Sep; 91(1):5-11. PubMed ID: 12851812
[TBL] [Abstract][Full Text] [Related]
11. Convenient Synthesis of Alternatively Bridged Tryptophan Ketopiperazines and Their Activities against Trypanosomatid Parasites.
Cockram PE; Turner CA; Slawin AMZ; Smith TK
ChemMedChem; 2022 Feb; 17(4):e202100664. PubMed ID: 34927802
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of Minor Groove Binders as anti-Trypanosoma brucei brucei therapeutics.
Scott FJ; Khalaf AI; Giordani F; Wong PE; Duffy S; Barrett M; Avery VM; Suckling CJ
Eur J Med Chem; 2016 Jun; 116():116-125. PubMed ID: 27060763
[TBL] [Abstract][Full Text] [Related]
13. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.
Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA
ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440
[TBL] [Abstract][Full Text] [Related]
14. Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode.
Spinks D; Smith V; Thompson S; Robinson DA; Luksch T; Smith A; Torrie LS; McElroy S; Stojanovski L; Norval S; Collie IT; Hallyburton I; Rao B; Brand S; Brenk R; Frearson JA; Read KD; Wyatt PG; Gilbert IH
ChemMedChem; 2015 Nov; 10(11):1821-36. PubMed ID: 26395087
[TBL] [Abstract][Full Text] [Related]
15. Antikinetoplastid SAR study in 3-nitroimidazopyridine series: Identification of a novel non-genotoxic and potent anti-T. b. brucei hit-compound with improved pharmacokinetic properties.
Fersing C; Boudot C; Paoli-Lombardo R; Primas N; Pinault E; Hutter S; Castera-Ducros C; Kabri Y; Pedron J; Bourgeade-Delmas S; Sournia-Saquet A; Stigliani JL; Valentin A; Azqueta A; Muruzabal D; Destere A; Wyllie S; Fairlamb AH; Corvaisier S; Since M; Malzert-Fréon A; Di Giorgio C; Rathelot P; Azas N; Courtioux B; Vanelle P; Verhaeghe P
Eur J Med Chem; 2020 Nov; 206():112668. PubMed ID: 32795774
[TBL] [Abstract][Full Text] [Related]
16. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
17. Designing Antitrypanosomal and Antileishmanial BODIPY Derivatives: A Computational and In Vitro Assessment.
Gonçalves RCR; Teixeira F; Peñalver P; Costa SPG; Morales JC; Raposo MMM
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731562
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.
Ronga L; Del Favero M; Cohen A; Soum C; Le Pape P; Savrimoutou S; Pinaud N; Mullié C; Daulouede S; Vincendeau P; Farvacques N; Agnamey P; Pagniez F; Hutter S; Azas N; Sonnet P; Guillon J
Eur J Med Chem; 2014 Jun; 81():378-93. PubMed ID: 24858543
[TBL] [Abstract][Full Text] [Related]
19. Curcuminoid analogs with potent activity against Trypanosoma and Leishmania species.
Changtam C; de Koning HP; Ibrahim H; Sajid MS; Gould MK; Suksamrarn A
Eur J Med Chem; 2010 Mar; 45(3):941-56. PubMed ID: 20004045
[TBL] [Abstract][Full Text] [Related]
20. Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D.C.
Ganfon H; Bero J; Tchinda AT; Gbaguidi F; Gbenou J; Moudachirou M; Frédérich M; Quetin-Leclercq J
J Ethnopharmacol; 2012 May; 141(1):411-7. PubMed ID: 22440261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
